Financials and Estimates

Figures converted from Indian rupees at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Financials and Estimates

Sunteck's income statement has inflected hard: revenue roughly tripled from a $44M trough in FY2023 to $125M in FY2026, and profit went from breakeven to $22M. But the cash statement tells a second story — FY2026 operating cash flow was negative $48M, the first outflow since FY2022, as the company poured collections and fresh capital into land and inventory. Balance-sheet risk stays low; returns on equity do not yet match the profit headline.

Figures are consolidated, in US dollars, unless stated. This chapter surfaces the three-year record and the forward estimates as a standalone view; the balance-sheet and pipeline framing is set in The Fallen Star.

The three-year record

Sources: FY2026 P&L and leverage — Q4 & FY26 investor presentation [1], [2]; ROE derived from reported financials.

Revenue nearly doubled in two years and profit ran far ahead of it: FY2026 operating revenue was $125M against $100M in FY2025 and $68M in FY2024, while PAT of $22M followed $18M and $9M [3], [4]. The starting point matters: FY2023 was effectively breakeven, with consolidated revenue of $44M and profit after tax of $0.2M (EPS $0.001) [5]. Measured off that trough the recovery looks dramatic; measured off FY2019, when the group earned roughly $34M, FY2026 is closer to a return to prior form than a new peak.

Sources: FY2024–FY2026 from Q4 & FY26 investor presentation [6]; FY2022–FY2023 from FY2023 Annual Report P&L [7].

Two features of this business shape how the numbers read. First, revenue is lumpy by design: Sunteck recognises income on completed or handed-over inventory, so a single tower's completion can swing a year, and the $44M FY2023 dip was recognition timing, not a collapse in demand. Second, margins are widening as the mix shifts — EBITDA margin rose from 21% in FY2024 to 27% in FY2026, and net margin from 12.6% to 18.0% [8].

Source: derived from reported financials, FY2022–FY2026 consolidated results [9].

The gap between the two lines matters: net margin has climbed to a healthy 18%, but return on equity — even in a record year — is only 5.6%, up from 2.3% in FY2024 [10]. A developer that earns roughly 5–6% on its book, trading near book value, is not cheap on current earning power; the case has to rest on the appraised value of the land and pipeline that book carries, not on the profit-and-loss statement as it stands. That is a question for the asset-value work, not this chapter.

Where the profit went: cash conversion

Through FY2025, reported earnings converted to cash well — cumulative operating cash flow across FY2023–FY2025 was $67M against cumulative PAT of $26M. FY2026 broke that pattern. Operating cash flow was negative $48M, and free cash flow negative $66M, the weakest since the pandemic year.

Source: consolidated statements of cash flow as reported in filed annual results, FY2022–FY2026; FY2023 statement [11].

The mechanism is inventory. The consolidated balance sheet's inventory line rose from $725M at FY2025 to $879M at FY2026 — a $188M build of land and work-in-progress that a developer books through working capital. Collections were strong (gross cash collections of $160M, up from $147M), but the year's deployment ran well ahead of them. Management frames the same facts differently: it reports a "Net Cash Flow Surplus" of $61M, then discloses $91M "spent on BD/LO/JDA" — business development, land options and joint-development costs — on the line directly below [12]. Counting that $91M — which was 4x FY2026 profit and up from $21M the prior year — the surplus becomes a deficit, which is what the statutory cash flow shows.

This is discretionary growth spending, not distress: the outflow bought roughly $560M of new gross pipeline value, and it was financed, not forced. The result, though, is a builder whose record profits did not turn into free cash in FY2026 because it chose to consume cash to expand. Whether that reinvestment earns its keep is what the estimates below test.

Balance sheet: low risk, on any definition

For a reader who wants the chance of bankruptcy near zero, the balance sheet is the reassuring part of the file. Net worth grew to $498M, and even after the FY2026 land spend, management reports net debt of just $30M — a net-debt-to-equity ratio of 0.06x, with an AA long-term rating from India Ratings (Fitch) [13].

Source: Q4 & FY26 investor presentation, net-debt bridge ($M) [14].

One line in that bridge deserves a reader's attention. Management's $30M net-debt figure nets out $43M of "Loans to JDA partners" as if it were cash. Strip that credit and count only actual cash against gross debt of $83M, and net debt is closer to $73M — still just 0.15x net worth. The distinction matters for how "fortress" the balance sheet is (the JDA loans are advances to partners on specific projects, not liquid cash), but it does not change the conclusion: gearing is low on either definition, and the maturity of gross debt is small against $498M of equity. The company also carries $879M of inventory — largely land and projects under development — so the assets backing that equity are real, if illiquid.

A second nuance sits behind the net-worth figure. Strip the $96M of one-year-old NCI (only $7M of it cash) from Sunteck's $498M net worth and a Sunteck share owns just $402M, turning the '1.0x book / 10% of GDV' cheapness into ~1.26x owners' book with the market paying $106M — 2.3% of GDV — for the entire development surplus. That non-controlling interest grew during FY2026 alongside a preferential capital raise; the full ownership and capital-structure treatment is carried in The Downside Floor.

Forward estimates: bullish targets, softening at the edges

Eleven-to-twelve analysts cover the stock, and the consensus is uniformly positive on both the numbers and the price. Revenue is expected to grow to roughly $155M in FY2027 and $183M in FY2028; EPS is seen rising from $0.16 actual to about $0.20 and $0.23 over the same two years — implying forward P/E of 16.6x on FY2027 and 14.0x on FY2028 against 22.6x trailing.

Source: FY2024–FY2026 as reported (investor presentation [15]); FY2027–FY2028 consensus of 11 analysts, as compiled.

Every one of the twelve covering analysts rates the stock a buy or strong buy, with a mean price target of $5.37 and a median of $5.36 against a $3.27 share price — roughly 64% above the market, with a range of $4.42 to $6.34, as compiled. On its face this is the setup a fallen-star investor looks for: a stock the tape has halved, and a covering analyst base that still sees substantial upside.

The honest caveat is in the revision trend. Over the last 90 days the consensus FY2027 EPS estimate has been cut from about $0.22 to $0.20, and in the most recent week six analysts trimmed their forward numbers against one raise — the estimates are drifting down even as the targets stay high. Consensus here is a starting point, not a verdict: the price targets assume the $91M the company just deployed converts into pre-sales and, eventually, recognised revenue on management's timeline. That conversion, not the current profit, is what the forward numbers are really underwriting.

What would change the read

The financial file supports a measured, two-sided read. The income statement has genuinely inflected and margins are widening; the balance sheet carries near-zero solvency risk on any definition, which addresses the bankruptcy concern directly. Against that, return on equity is still only 5.6%, FY2026 free cash flow was deeply negative on discretionary land spend, and forward estimates — though attached to bullish targets — are being revised down. A single year of positive operating cash flow with the pipeline converting to recognised revenue would confirm the reinvestment is working; a second year of negative operating cash flow without a step-up in pre-sales conversion would suggest the $91M was growth for its own sake.